← Back to Search

Treatment for Polycystic Ovary Syndrome

N/A
Waitlist Available
Led By Aviva Sopher, MD, MS, MS
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights
No Placebo-Only Group

Summary

This trial will observe whether adolescents with Polycystic Ovary Syndrome (PCOS) are more likely to have elevated liver fat than controls, and assess the associated biomarkers.

Eligible Conditions
  • Polycystic Ovary Syndrome
  • Metabolic Syndrome
  • Non-alcoholic Fatty Liver Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Difference in percentage liver fat between PCOS and controls in adolescents and young adults
Secondary study objectives
The association of percentage liver fat by magnetic resonance spectroscopy with insulin resistance as measured by HOMA-IR.
The association of percentage liver fat by magnetic resonance spectroscopy with total body adipose tissue
The association of percentage liver fat by magnetic resonance spectroscopy with triglycerides
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,483 Previous Clinical Trials
2,629,915 Total Patients Enrolled
2 Trials studying Polycystic Ovary Syndrome
47 Patients Enrolled for Polycystic Ovary Syndrome
Aviva Sopher, MD, MS, MSPrincipal InvestigatorColumbia University
~7 spots leftby Oct 2025